Pascale currently serves on the board of Fresenius Medical Care AG, Revvity, Inc. and Regulus Therapeutics, Inc., where she provides governance, financial oversight, and executive mentorship. She previously served on the boards of Horizon Therapeutics plc, Tesaro Bio, Inc., and Arkuda Therapeutics, Inc., until their acquisitions by Amgen, Inc., GSK plc and Johnson & Johnson, Inc. respectively. Additionally, Pascale serves on the boards of INSEAD and of the Global Alzheimer Platform Foundation.